Literature DB >> 26489654

An intrinsic mechanism of secreted protein aging and turnover.

Won Ho Yang1, Peter V Aziz1, Douglas M Heithoff2, Michael J Mahan2, Jeffrey W Smith3, Jamey D Marth4.   

Abstract

The composition and functions of the secreted proteome are controlled by the life spans of different proteins. However, unlike intracellular protein fate, intrinsic factors determining secreted protein aging and turnover have not been identified and characterized. Almost all secreted proteins are posttranslationally modified with the covalent attachment of N-glycans. We have discovered an intrinsic mechanism of secreted protein aging and turnover linked to the stepwise elimination of saccharides attached to the termini of N-glycans. Endogenous glycosidases, including neuraminidase 1 (Neu1), neuraminidase 3 (Neu3), beta-galactosidase 1 (Glb1), and hexosaminidase B (HexB), possess hydrolytic activities that temporally remodel N-glycan structures, progressively exposing different saccharides with increased protein age. Subsequently, endocytic lectins with distinct binding specificities, including the Ashwell-Morell receptor, integrin αM, and macrophage mannose receptor, are engaged in N-glycan ligand recognition and the turnover of secreted proteins. Glycosidase inhibition and lectin deficiencies increased protein life spans and abundance, and the basal rate of N-glycan remodeling varied among distinct proteins, accounting for differences in their life spans. This intrinsic multifactorial mechanism of secreted protein aging and turnover contributes to health and the outcomes of disease.

Entities:  

Keywords:  glycosidase; glycosylation; homeostasis; lectin; protein

Mesh:

Substances:

Year:  2015        PMID: 26489654      PMCID: PMC4640737          DOI: 10.1073/pnas.1515464112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity.

Authors:  Nicholas M Stamatos; Ivan Carubelli; Diantha van de Vlekkert; Erik J Bonten; Nadia Papini; Chiguang Feng; Bruno Venerando; Alessandra d'Azzo; Alan S Cross; Lai-Xi Wang; Peter J Gomatos
Journal:  J Leukoc Biol       Date:  2010-09-08       Impact factor: 4.962

2.  Lysosomal exoglycosidases in serum and urine of patients with pancreatic adenocarcinoma.

Authors:  Sławomir Dariusz Szajda; Napoleon Waszkiewicz; Anna Stypułkowska; Jacek Dadan; Krzysztof Zwierz
Journal:  Folia Histochem Cytobiol       Date:  2010-09-30       Impact factor: 1.698

3.  Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.

Authors:  Keiko Hata; Koichi Koseki; Kazunori Yamaguchi; Setsuko Moriya; Yasuo Suzuki; Sangchai Yingsakmongkon; Go Hirai; Mikiko Sodeoka; Mark von Itzstein; Taeko Miyagi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

4.  Modification of triantennary glycopeptide into probes for the asialoglycoprotein receptor of hepatocytes.

Authors:  K G Rice; Y C Lee
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

5.  Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.

Authors:  E Bonten; A van der Spoel; M Fornerod; G Grosveld; A d'Azzo
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

6.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

Authors:  A Coxon; P Rieu; F J Barkalow; S Askari; A H Sharpe; U H von Andrian; M A Arnaout; T N Mayadas
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

7.  Segmental genomic replacement in embryonic stem cells by double lox targeting.

Authors:  S Soukharev; J L Miller; B Sauer
Journal:  Nucleic Acids Res       Date:  1999-09-15       Impact factor: 16.971

8.  Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.

Authors:  Brigitte A Rigat; Michael B Tropak; Justin Buttner; Ellen Crushell; Daphne Benedict; John W Callahan; Douglas R Martin; Don J Mahuran
Journal:  Mol Genet Metab       Date:  2012-06-19       Impact factor: 4.797

9.  Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor.

Authors:  Prabhjit K Grewal; Peter V Aziz; Satoshi Uchiyama; Gabriel R Rubio; Ricardo D Lardone; Dzung Le; Nissi M Varki; Victor Nizet; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-27       Impact factor: 11.205

10.  The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.

Authors:  Renata Grozovsky; Antonija Jurak Begonja; Kaifeng Liu; Gary Visner; John H Hartwig; Hervé Falet; Karin M Hoffmeister
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

View more
  36 in total

1.  Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting.

Authors:  Megan Aarnio-Peterson; Peng Zhao; Seok-Ho Yu; Courtney Christian; Heather Flanagan-Steet; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2017-07-19       Impact factor: 5.157

Review 2.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

3.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

Review 4.  Glycomics: revealing the dynamic ecology and evolution of sugar molecules.

Authors:  Stevan A Springer; Pascal Gagneux
Journal:  J Proteomics       Date:  2015-11-25       Impact factor: 4.044

Review 5.  Manipulation of the glycan-specific natural antibody repertoire for immunotherapy.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

6.  Recurrent infection progressively disables host protection against intestinal inflammation.

Authors:  Won Ho Yang; Douglas M Heithoff; Peter V Aziz; Markus Sperandio; Victor Nizet; Michael J Mahan; Jamey D Marth
Journal:  Science       Date:  2017-12-22       Impact factor: 47.728

7.  Human Plasma N-glycosylation as Analyzed by Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance-MS Associates with Markers of Inflammation and Metabolic Health.

Authors:  Karli R Reiding; L Renee Ruhaak; Hae-Won Uh; Said El Bouhaddani; Erik B van den Akker; Rosina Plomp; Liam A McDonnell; Jeanine J Houwing-Duistermaat; P Eline Slagboom; Marian Beekman; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2016-12-08       Impact factor: 5.911

8.  Glycoproteomic Analysis of Human Urinary Exosomes.

Authors:  Christopher J Brown; Stefan Gaunitz; Ziyu Wang; Lena Strindelius; Stephen C Jacobson; David E Clemmer; Jonathan C Trinidad; Milos V Novotny
Journal:  Anal Chem       Date:  2020-10-13       Impact factor: 6.986

9.  Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.

Authors:  Haiying Zhang; Daniela Freitas; Han Sang Kim; Kristina Fabijanic; Zhong Li; Haiyan Chen; Milica Tesic Mark; Henrik Molina; Alberto Benito Martin; Linda Bojmar; Justin Fang; Sham Rampersaud; Ayuko Hoshino; Irina Matei; Candia M Kenific; Miho Nakajima; Anders Peter Mutvei; Pasquale Sansone; Weston Buehring; Huajuan Wang; Juan Pablo Jimenez; Leona Cohen-Gould; Navid Paknejad; Matthew Brendel; Katia Manova-Todorova; Ana Magalhães; José Alexandre Ferreira; Hugo Osório; André M Silva; Ashish Massey; Juan R Cubillos-Ruiz; Giuseppe Galletti; Paraskevi Giannakakou; Ana Maria Cuervo; John Blenis; Robert Schwartz; Mary Sue Brady; Héctor Peinado; Jacqueline Bromberg; Hiroshi Matsui; Celso A Reis; David Lyden
Journal:  Nat Cell Biol       Date:  2018-02-19       Impact factor: 28.824

Review 10.  Glycobiology simplified: diverse roles of glycan recognition in inflammation.

Authors:  Ronald L Schnaar
Journal:  J Leukoc Biol       Date:  2016-03-22       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.